SCHEMBL19009555

SCHEMBL19009555

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4cccc(-c5ccc(-c6ccccn6)cc5)c4)n3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.50
MEN1 O00255 5/20 0.50
KMT2A Q03164 5/20 0.50
RAB9A P51151 5/20 0.50
ALDH1A1 P00352 4/20 0.50
MAPT P10636 4/20 0.50
HPGD P15428 4/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
LMNA P02545 4/20 0.50
TP53 P04637 3/20 0.50
TDP1 Q9NUW8 2/20 0.50
PKM P14618 2/20 0.50
TSHR P16473 1/20 0.50
KLF5 Q13887 1/20 0.50
HSD17B10 Q99714 1/20 0.50
NPC1 O15118 3/20 0.47
GLA P06280 1/20 0.47
GRM5 P41594 1/20 0.47
NTSR1 P30989 1/20 0.46
ALPL P05186 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17932568 1.00 KDM4E (0.50) KDM4EMEN1KMT2ARAB9AALDH1A1
SCHEMBL19009560 1.00 KDM4E (0.50) KDM4EMEN1KMT2ARAB9AALDH1A1
SCHEMBL19009463 1.00 KDM4E (0.50) KDM4EMEN1KMT2ARAB9AALDH1A1
SCHEMBL18327458 1.00 KDM4E (0.50) KDM4EMEN1KMT2ARAB9AALDH1A1
SCHEMBL17598683 0.98 KDM4E (0.52) KDM4EMEN1KMT2ARAB9AALDH1A1
SCHEMBL19497458 0.97 KDM4E (0.48) KDM4EMEN1KMT2ARAB9AALDH1A1
SCHEMBL21982133 0.97 KDM4E (0.50) KDM4EMEN1KMT2ARAB9AALDH1A1
SCHEMBL25460898 0.95 KDM4E (0.49) KDM4EMEN1KMT2ARAB9AALDH1A1
SCHEMBL2948986 0.95 KDM4E (0.49) KDM4EMEN1KMT2ARAB9AALDH1A1
SCHEMBL19238734 0.95 KDM4E (0.52) KDM4EMEN1KMT2ARAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 KDM4E 2540/4885MEN1 2816/4885KMT2A 1971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.